Anthony Gibney
Equibles does not estimate personal net worth.
Get an email with a short summary when Aura Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get AURA alertsAbout Anthony Gibney
Anthony Gibney is recorded as CFO at Aura Biosciences, Inc. (AURA) since May 13, 2025. Aura Biosciences, Inc. reported in an 8-K filed August 11, 2026 that Anthony Gibney resigned as Chief Financial and Business Officer, effective September 1, 2026. Aura Biosciences, Inc. reported in an 8-K filed May 15, 2025 that Anthony Gibney was appointed Chief Financial and Business Officer, effective May 13, 2025. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aura Biosciences, Inc. includes Elisabet de los Pinos (CEO and Board Member), Natalie Holles (CEO and Board Member), Amy Elazzouzi (CFO and Chief Accounting Officer) and 7 others.
“On August 10, 2026, the Company and Anthony Gibney, the Company's Chief Financial and Business Officer, entered into a Separation Agreement (the "Gibney Separation Agreement"), effective as of September 1, 2026 (the "Gibney Separation Date").”
“Effective as of May 13, 2025 (the "Effective Date"), the Board of Directors of the Company appointed Anthony Gibney as the Company's Chief Financial and Business Officer.”
Affiliation history
-
Aura Biosciences, Inc. (AURA)
Proxy statement
Current2025-05-13–present
Last confirmed April 20, 2026
-
Current
2025-05-13–present
Company network
Leadership on record at Aura Biosciences, Inc.
- Elisabet de los Pinos CEO, Board Member
- Natalie Holles CEO, Board Member
- Amy Elazzouzi CFO, Chief Accounting Officer
- Julie B. Feder CFO
- Mark De Rosch COO
- Susan Abu-Absi COO
- Mark Plavsic CTO
- Conor Kilroy General Counsel
- David Johnson Board Member
- Jeremy Bender, Ph.D., M.B.A. Board Member